NCT00626522View on ClinicalTrials.gov

Aclidinium/Formoterol Fixed Combination Dose Finding Study

PHASE2CompletedINTERVENTIONAL
Enrollment

808

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Aclidinium bromide and formoterol

once daily

DRUG

Aclidinium bromide and formoterol placebo

once daily

Trial Locations (9)

Unknown

Research Site, Taichung

Research Site, Taipei

Research Site, Moscow

Research Site, Saint Petersburg

Research Site, St-Petersburg

Research Site, Moscow

Research Site, Saint Petersburg

Research Site, Saratov

Research Site, Yaroslavl

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY